Rockefeller Capital Management L.P. Abcam PLC Transaction History

Rockefeller Capital Management L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$13.92 - $17.0 $17,511 - $21,386	-1,258 Reduced 41.92%	1,743 $27,000
Q3 2022 Nov 02, 2022	BUY	$13.36 - $16.75 $1,095 - $1,373	82 Added 2.81%	3,001 $44,000
Q2 2022 Aug 12, 2022	SELL	$12.69 - $19.25 $1,332 - $2,021	-105 Reduced 3.47%	2,919 $42,000
Q1 2022 May 13, 2022	BUY	$15.5 - $23.89 $27,032 - $41,664	1,744 Added 136.25%	3,024 $54,000
Q4 2021 Feb 14, 2022	BUY	$20.04 - $23.84 $7,134 - $8,487	356 Added 38.53%	1,280 $28,000
Q3 2021 Nov 12, 2021	BUY	$17.38 - $21.54 $1,459 - $1,809	84 Added 10.0%	924 $18,000
Q2 2021 Aug 10, 2021	BUY	$18.47 - $22.11 $15,514 - $18,572	840 New	840 $15,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.